pergolide has been researched along with Parkinsonian Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciobica, A; Hritcu, L; Olteanu, Z; Padurariu, M | 1 |
| Cannizzaro, C; Jackson, MJ; Jenner, P; Maratos, EC; Pearce, RK | 1 |
| Kuwabara, T | 1 |
| Betz, A; Carlson, BB; Correa, M; Lentini, E; Rios, C; Salamone, JD; Wisniecki, A | 1 |
| de Freitas, GR; Fontenelle, LF; Garcia, RF; Mendlowicz, MV; Nazar, BP; Ordacgi, L; Rosso, AL | 1 |
| Bordet, R; Derambure, P; Destée, A; Houdayer, E; Jacquesson, JM; Laloux, C; Monaca, C | 1 |
| Barbanoj, M; Casas, M; Jané, F; Prat, G; Robledo, P; Rubio, A | 1 |
| Brannan, T; Prikhojan, A; Yahr, MD | 1 |
| Masson, C | 1 |
9 other study(ies) available for pergolide and Parkinsonian Disorders
| Article | Year |
|---|---|
The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Dopamine Agonists; Glutathione Peroxidase; Linear Models; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Wistar; Superoxide Dismutase; Temporal Lobe | 2012 |
Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Motor Activity; Parkinsonian Disorders; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Severity of Illness Index | 2003 |
[Pergolide-induced pleural effusion in a patient with juvenile parkinsonism].
Topics: Dopamine Agonists; Humans; Male; Middle Aged; Parkinsonian Disorders; Pergolide; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis | 2002 |
Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
Topics: Analysis of Variance; Animals; Cholinergic Agents; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Jaw; Male; Movement; Movement Disorders; Parkinsonian Disorders; Pergolide; Phenanthridines; Rats; Rats, Sprague-Dawley; Tacrine | 2005 |
Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gambling; Humans; Levodopa; Parkinsonian Disorders; Pergolide; Pramipexole; Recurrence | 2007 |
Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice.
Topics: Animals; Dopamine Agonists; Electroencephalography; Levodopa; Lisuride; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Pergolide; Polysomnography; Sleep; Wakefulness | 2008 |
Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats.
Topics: Animals; Bromocriptine; Caffeine; Denervation; Drug Administration Schedule; Drug Combinations; Drug Tolerance; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Sprague-Dawley; Rotation | 2000 |
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 2000 |
[Parkinson's disease].
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors | 2001 |